Nature Review: AI in drug discovery shows limited clinical impact, calls for focus on decision-making
Sufficient_Okra_2919 · reddit · 2026-08-08
A Perspective in Nature Reviews Drug Discovery critically reviews AI in drug discovery, noting limited clinically relevant impact despite many methods. Reasons include insufficient focus on clinical translation, conditional data, and underspecification. Recommendations include benchmarking for decision improvement.
Related event: Nature Review: AI Drug Discovery Lacks Clinical Impact(2 posts)→
More from Research
- CWoMP accepted to EMNLP 2026: Interpretable retrieval-based glossing for endangered languages — fredahshi · 2026-08-24
- SemiAnalysis Open Sources $3M AgentX Benchmark for Agentic Coding Workloads — AccBalanced · 2026-08-24
- Vinci2 Agent Outperforms GPT-5-mini in Proactive Assistance Benchmark — jiqizhixin · 2026-08-24
- OpenAI hiring for Economics of Transformative AI, MATS fellowship applications open — Astral Codex Ten · 2026-08-24
- New "Discovery Episode" Framework Measures AI Scientists by Real Research Cycles — 量子位 · 2026-08-24
- AI Claims Breakthrough on Erdős Problem Transcendence — inductionheads · 2026-08-24